Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × bemarituzumab × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 4 OTHER 2 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

GastroEsophageal Cancer 1

Interventions

Specimen Handling 64 Magnetic Resonance Spectroscopy 51 Cyclophosphamide 44 Vincristine 38 Radiotherapy 32 Radiation 31 Cisplatin 31 Carboplatin 28 Dexamethasone 27 Etoposide 25 Doxorubicin 25 Biopsy 23 Prednisone 18 daratumumab 17 Radiotherapy, Intensity-Modulated 17 Platinum 16 Cytarabine 16 durvalumab 15 Irinotecan 15 Gemcitabine 15 1,2-diaminocyclohexaneplatinum II citrate 15 Paclitaxel 14 Methotrexate 14 Docetaxel 14 Observation 13 Leucovorin 13 Lenalidomide 13 Fluorouracil 12 Calcium Dobesilate 12 merphos 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06978062 2025-06-05

NeoBEMA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Not yet recruiting

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡